ABSTRACT OBJECTIVES The aim of this review is to describe the incidence, features, predisposing factors, and outcomes of prosthetic valve endocarditis (PVE) after transcatheter valve replacement (TVR).
Categorical variables were reported as n (%), and continuous variables as mean AE SD or median (25th to 75th interquartile range) depending on variable distribution.
RESULTS
A total of 60 patients who underwent TVR, including 32 TAVR (1-16) and 28 TPVR (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) , and who had PVE were included in the study. All cases were published between 2006 and 2013 (Online Table 1 for bibliographic sources and type of articles). The main baseline characteristics of TAVR and TPVR populations are summarized in Tables 1 and 2 , respectively. The mean age of TAVR patients was 80 AE 7 years, 66% of them were men, and the mean logistic EuroSCORE was 30.4 AE 14.0%. A comparison of these data with the data on the patients included large TAVR registries, the PARTNER trial (Online Refs. [6] [7] [8] [9] [19] [20] [21] [22] , and in surgical studies (Online Refs. [22] [23] [24] [25] is shown in Tables 1 and 2, respectively. Of the TAVR patients, 58% had received 
Amat-Santos et al. The 3 main sources (dental and respiratory/skin infections) were the same for both types of TVR, but a health care-related origin was more common in TAVR patients (42.1%) than in TPVR patients (18.2%) (p ¼ 0.246). The source of infection remained undetermined in as many as 50% of the patients. Very little information was provided on the management of PVE prophylaxis after the TVR procedure, and failure to comply with recommendations was reported in 2 cases (18, 22) . A history of PVE existed in 2 pulmonary cases.
In 2 cases, only criteria for "possible" PVE were achieved, but given the high suspicion, they were finally included in the present review (7, 8) . Amat-Santos et al. The location of PVE as determined by transesophageal echocardiography is schematically depicted in Figure 6 . The presence of vegetation was detected in 58.3% of the patients (50.0% and 68.4% in the TAVR and TPVR groups, respectively). In the TAVR group, the vegetation was located on the transcatheter valve leaflets in 7 patients (21.9%), on the valve stent frame in 2 patients (6.2%), and affected both structures in 3 patients (9.2%). Also, tricuspid and mitral valves presented vegetation in 1 (3.1%) and 3 patients (9.4%), respectively. The infection was restricted to the prosthetic valve in all TPVR cases ( Table 5) . No valve involvement could be confirmed in 4 patients (3 patients in the TAVR group and 1 in the TPVR group), with initial criteria for definite PVE and good response to antibiotic therapy.
The main microbiological findings differed in the TAVR and TPVR groups ( Table 5) . Although Enterococcus was the most frequent microorganism responsible for PVE in TAVR patients (34.4%), Staphylococcus aureus was predominant among TPVR patients (29.4%). Globally, positive cultures for patients, all cultures including those performed after valve explantation, remained negative, but previous antibiotic therapy had been administered in both cases before blood samples were obtained.
MANAGEMENT AND OUTCOMES OF TVR-RELATED PVE.
All patients received antibiotic therapy according to the etiology of PVE. Cardiac surgery and valve explantation were performed in 13 patients (41%) in the TAVR group and in 21 patients (75%) in the TPVR group. In the TAVR group, the rate of PVErelated surgery was twice as high in patients who had received a balloon-expandable valve (57%) compared with those who had a self-expandable valve (23%), despite a similar baseline risk profile in both groups as evaluated by the logistic EuroSCORE (30.5 AE 15.6% vs. 27.8 AE 13.5% in balloon-and selfexpandable groups, respectively).
The most important surgical findings included incomplete valve endothelialization several months after TAVR in 1 case and sinotubular junction penetration by the struts in another case (Online Refs. 14,34).
The in-hospital mortality rate was 34.4% in the TAVR group, 30.8% in those patients who had surgery and valve explantation and 36.8% in those managed medically. In the TPVR group, the in-hospital mortality rate associated with the episode of PVE was 7.1%, 9.5% in patients who required surgery and none in those managed medically. Follow-up data were available in 15 patients in the TAVR group (47% of study population, 71% of the patients alive at hospital discharge), with a mean length of follow-up of 11 AE 9 months. Two additional cases of PVE-related death were reported in this period, at 1 and 3 months after hospital discharge. No follow-up information was available for patients treated with TPVR, which precludes long-term prognostic conclusions.
The rates of surgical management and mortality in TAVR and TPVR groups are summarized in Table 5 . Amat-Santos et al. These "contaminant" germs were also a frequent etiology of early PVE after TAVR (36.7%), with enterococci as the predominant causative agents of early PVE in this group ( Table 5) . Previous studies predicted the increasing role of this pathogen as life expectancy increases and more aggressive therapies are administered to aged patients (Online Refs. 5,35).
Enterococci are highly tolerant to antibiotic-induced Amat-Santos et al.
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Infective Endocarditis and Transcatheter Valves 11,12) . Indeed, about two-thirds of the patients with heart failure at admission were not operated on despite the proven survival benefits of surgery in that scenario (Online Refs. 11,41).
The rate of valve explantation observed in PVE post-TPVR was as high as 75%. Apart from the fact that the TPVR population is much younger than the Tables 2 and 3. usual IE patients, the right-side location (Online Amat-Santos et al.
Infective Endocarditis and Transcatheter Valves Additionally, the patients reported might have tended to have a better outcome than those who were not reported (selection bias).
CONCLUSIONS
PVE is an uncommon but life-threatening complication after TVR. Although the conditions of asepsis are frequently less strict than in surgical interventions, the incidence of early PVE post-TVR remains low (usually #1%) and similar to that of surgical series. In the TAVR population, this complication seems to be more frequent in male patients and in those with higher risk profile. In TPVR patients, PVE seems to occur more frequently in male patients with a stenotic (vs. regurgitation) conduit/ valve as the main underlying disease. Although early PVE is considered to be acquired during the periprocedural time, the low rate of classic contaminant agents in favor of others such as enterococci, especially among TAVR patients, may suggest alternative source of infection. This is of major clinical importance because alternative antibiotic prophylaxis protocols may reduce the incidence of the disease.
About two-thirds of the TAVR-PVE patients were managed medically, despite the fact that more than one-half of the patients had complications such as local extension, embolism, and heart failure. The mortality rate of PVE in these patients was high (more than 30%) and similar to that described in previous PVE studies. Most TPVR-PVE patients were managed surgically and underwent surgical explantation of the infected conduit valve. However, the mortality rate remained at 7% despite the very young age of this population. Abbreviations as in Tables 1 to 3 . Amat-Santos et al.
